Targeted Memory Erasure in Mice Perfected by US Scientists

by Rajashri on October 23, 2008 at 1:21 PM
 Targeted Memory Erasure in Mice Perfected by US Scientists

In a major development, US researchers have been able to selectively erase memories from mice in a laboratory, thus raising hopes human memory afflictions like post-traumatic stress syndrome can one day be cured.

"Targeted memory erasure is no longer limited to the realm of science fiction," the research team headed by Joe Tsien, from the Brain and Behavior Discovery Institute at the Medical College of Georgia, said in Thursday's issue of Cell Press magazine.


The new technique, which the team stress is at a very early stage, could be applied one day to the human brain to erase traumatic memories or deep-set fears, and leave all other memories unaffected.

Memory is generally separated into four different stages: acquisition, consolidation, storage, and retrieval. Earlier research identified specific molecules that appear to play a role in the various phases of the memory process.

But Tsien said his team found a way to quickly manipulate the activity of the "memory molecule," the protein CaMKII (calcium/calmodulin-dependent protein kinase II) that plays a key role in brain cell communication, and so is linked to many aspects of learning and memory.

Researchers developed a "chemical genetic strategy," which made it possible to manipulate the protein in transgenic mice, which had been bred to overproduce the molecule.

"Using this technique, we examined the manipulation of transgenic CaMKII activity on the retrieval of short-term and long-term fear memories and novel object recognition memory" in transgenic mice, Tsien said.

The team figured out they could manipulate the protein in the mice's brain as the animal was stimulated, and observe the brain's ability to recall memory of the stimulation.

Through the protein manipulation, researchers then found a way to not just block the mice's memory of the stimulation, but erase them without impacting the brain's ability to recall other memories.

Tsien became famous in 1999 for his creation of Doggie, the smart transgenic mouse with enhanced learning and memory abilities.

In the recent findings, Tsien's team found that transient excessive activity of CaMKII at the time of recall impaired retrieval of short- and long-term fear memories, as well as memories formed as recently as one hour.

They also showed that recall deficits linked to excessive CaMKII activity were not caused by a blockade of the recall process but instead seemed to be due to rapid erasure of the stored memories.

In addition, they found that the erased memories were limited to those being retrieved, while others remained intact.

"The results demonstrate a successful genetic method for rapidly and specifically erasing specific memories, such as new and old fear memories, in a controlled and inducible manner without doing harm to the brain cells," the researchers said.

Tsien said the technique might one day be applied to war veterans who "often suffer from reoccurring traumatic memory replays after returning home."

However, he warned that it was premature to expect a such a miracle cure.

"No one should expect to have a pill do the same in humans any time soon, we are barely at the foot of a very tall mountain," he said.

Source: AFP
Font : A-A+



Recommended Readings

Latest Research News

Does Twice Daily Stimulation Enhance Alzheimer's Mental Functions?
Electrical stimulation improves Alzheimer's patients' cognitive function and correlates with restored cortical plasticity.
South Korea's 2050 Forecast: Negative Growth Amid Low Fertility
South Korea's total fertility rate, averaging the number of children a woman aged 15-49 has in her lifetime, dropped to 0.81.
New Immunotherapy for Psoriasis & Vitiligo
Scientists identified mechanisms governing immune cells, selectively removing troublemakers to reshape skin immunity. Benefits those with psoriasis, vitiligo.
2050 Forecast: 1.06 Billion Individuals to Face 'Other' Musculoskeletal Disorders
By 2050, an anticipated increase from 494 million cases in 2020 to 1.06 billion people with musculoskeletal disabilities is expected.
Gene Therapies Can Disrupt Gaucher Disease Drug Market
Experts consulted by GlobalData anticipate a significant overhaul in the Gaucher disease scenario because of forthcoming gene therapies in development.
View All
This site uses cookies to deliver our services.By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use  Ok, Got it. Close

Targeted Memory Erasure in Mice Perfected by US Scientists Personalised Printable Document (PDF)

Please complete this form and we'll send you a personalised information that is requested

You may use this for your own reference or forward it to your friends.

Please use the information prudently. If you are not a medical doctor please remember to consult your healthcare provider as this information is not a substitute for professional advice.

Name *

Email Address *

Country *

Areas of Interests